"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
100,"no","yes","Genetically Predicted Body Mass Index and Alzheimer’s Disease Related Phenotypes in Three Large Samples: Mendelian Randomization Analyses",2015,"Alzheimers and Dementia","10.1016/j.jalz.2015.05.015.","Mukherjee","Paul K. Crane","pcrane@uw.edu","Department of Medicine, Box 359780, 325 Ninth Avenue, Seattle, WA 98104, USA","Effect of body mass index on Alzheiumers","Observational research shows that higher body mass index (BMI) increases Alzheimer’s disease (AD) risk, but it is unclear whether this association is causal.","One-sample","alzheimer's disease","Alzheimer's disease (in ADGC)","brain","NINCDS-ADRDA criteria for definite, probable or possible Alzheimer's disease and all controls were cognitively normal elders.","Current study",">60","both","10079","9613","10079","9613",NA,"Cases of AD and healthy ""normal elderly controls""","Europeans","BMI","BMI","Speliotes 2010 BMI Europeans both","108","both","249796","249796",NA,"Healthy","Europeans","3 principal components for ADGC and 6 for HRS (no mention of GERAD)","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Not discussed","P < 10−6",NA,NA,"31","32","They said that there were only 31 SNPs available in ADGC","Not discussed",NA,"Inverse variance weighted (fixed effects)","Overidentification tests",NA,NA,NA,NA,"Not clear what main analysis is - It's not actually clear in the methods what the authors did as their main analysis - they literally just say ""our primary MR analyses, we used each SNP and BMI polygenic scores to predict AD or dementia probability in logistic regression models to estimate odds ratios and 95% confidence intervals"" The over identification tests were used to compare the effect estimates from the 4 mechanism-specific polygenic scores - stating ""If associations between mechanism-specific scores and AD risk are statistically different, this would imply either a direct pathway linking genetic variants to AD that is not mediated by BMI, or that the different genetic subscores influence distinct types of adiposity, which in turn have distinct consequences on AD""","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","No","Not clear - they just say ""unit"" and then specify that BMI is measured in kg/m2 without much information in analyses section","Odds ratio","OR","0.95",NA,"95","0.9","1.01","9.0999999999999998E-2",NA,NA,"One caveat to our analyses is that BMI may be relevant for AD only above a certain threshold. Another concern is related to survivor bias. Both ADGC and the GERAD1 sample are AD case control studies among older individuals. BMI has strong and age-dependent links to mortality[40], thus our samples may have included a highly selected subgroup of “survivors” immune to the effects of obesity. A very similar bias should apply to conventional observational studies, however, so it is unlikely that this bias could explain differences between our results and previous work.","These SNPs were not associated with AD in ADGC or dementia in HRS. This does not conclusively prove the validity of our approach, but we note that even if there is modest pleiotropy, it is unlikely to explain our unexpected null associations.","Not discussed - they just state that they adjusted for principal components in their analyses to overcome population stratification","Statistical power is a common limitation in MR analyses, but the CIs in our analyses are informative and exclude any but very tiny harmful effects of BMI.","The authors also did some sensitivity analyses whereby they split the 32 SNP into four functional categories - adipogenesis, appetite, cardiopulmonary factors, and BMI-related processes not otherwise specified.",1472
100,"no","yes","Genetically Predicted Body Mass Index and Alzheimer’s Disease Related Phenotypes in Three Large Samples: Mendelian Randomization Analyses",2015,"Alzheimers and Dementia","10.1016/j.jalz.2015.05.015.","Mukherjee","Paul K. Crane","pcrane@uw.edu","Department of Medicine, Box 359780, 325 Ninth Avenue, Seattle, WA 98104, USA","Effect of body mass index on Alzheiumers","Observational research shows that higher body mass index (BMI) increases Alzheimer’s disease (AD) risk, but it is unclear whether this association is causal.","One-sample","alzheimer's disease","Alzheimer's disease (in GERAD)","brain","Probable (NINCDS-ADRDA, DSM-IV) or definite (CERAD) Alzheimer's disease","Current study",">60","both","3177","7277","3177","7277",NA,"Cases of dementia and controls confirmed to be free of dementia","Europeans","BMI","BMI","Speliotes 2010 BMI Europeans both","108","both","249796","249796",NA,"Healthy","Europeans","3 principal components for ADGC and 6 for HRS (no mention of GERAD)","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Not discussed","P < 10−6",NA,NA,"Not discussed","32","Not discussed","Not discussed",NA,"Inverse variance weighted (fixed effects)","Overidentification tests",NA,NA,NA,NA,"Not clear what main analysis is - It's not actually clear in the methods what the authors did as their main analysis - they literally just say ""our primary MR analyses, we used each SNP and BMI polygenic scores to predict AD or dementia probability in logistic regression models to estimate odds ratios and 95% confidence intervals"" The over identification tests were used to compare the effect estimates from the 4 mechanism-specific polygenic scores - stating ""If associations between mechanism-specific scores and AD risk are statistically different, this would imply either a direct pathway linking genetic variants to AD that is not mediated by BMI, or that the different genetic subscores influence distinct types of adiposity, which in turn have distinct consequences on AD""","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","No","Not clear - they just say ""unit"" and then specify that BMI is measured in kg/m2 without much information in analyses section","Odds ratio","OR","0.96",NA,"95","0.87","1.07","0.48799999999999999",NA,NA,"One caveat to our analyses is that BMI may be relevant for AD only above a certain threshold. Another concern is related to survivor bias. Both ADGC and the GERAD1 sample are AD case control studies among older individuals. BMI has strong and age-dependent links to mortality[40], thus our samples may have included a highly selected subgroup of “survivors” immune to the effects of obesity. A very similar bias should apply to conventional observational studies, however, so it is unlikely that this bias could explain differences between our results and previous work.","These SNPs were not associated with AD in ADGC or dementia in HRS. This does not conclusively prove the validity of our approach, but we note that even if there is modest pleiotropy, it is unlikely to explain our unexpected null associations.","Not discussed - they just state that they adjusted for principal components in their analyses to overcome population stratification","Statistical power is a common limitation in MR analyses, but the CIs in our analyses are informative and exclude any but very tiny harmful effects of BMI.","The authors also did some sensitivity analyses whereby they split the 32 SNP into four functional categories - adipogenesis, appetite, cardiopulmonary factors, and BMI-related processes not otherwise specified.",1475
100,"no","yes","Genetically Predicted Body Mass Index and Alzheimer’s Disease Related Phenotypes in Three Large Samples: Mendelian Randomization Analyses",2015,"Alzheimers and Dementia","10.1016/j.jalz.2015.05.015.","Mukherjee","Paul K. Crane","pcrane@uw.edu","Department of Medicine, Box 359780, 325 Ninth Avenue, Seattle, WA 98104, USA","Effect of body mass index on Alzheiumers","Observational research shows that higher body mass index (BMI) increases Alzheimer’s disease (AD) risk, but it is unclear whether this association is causal.","One-sample","alzheimer's disease","Alzheimer's disease (in both ADGC + GERAD)","brain","NINCDS-ADRDA criteria for definite, probable or possible Alzheimer's disease and all controls were cognitively normal elders (GERAD). Previously developed dementia probability score (probablility individuals meet DSM-IV criteria) that integrates proxy and direct cognitive assessments (in ADGC).","Current study",">60","both","Not discussed","Not discussed","Not discussed","Not discussed",NA,"Cases of AD and healthy ""normal elderly controls"" (ADGC) and Cases of dementia and controls confirmed to be free of dementia (GERAD)","Europeans","BMI","BMI","Speliotes 2010 BMI Europeans both","108","both","249796","249796",NA,"Healthy","Europeans","3 principal components for ADGC and 6 for HRS (no mention of GERAD)","Not discussed","Not discussed","Not discussed","5x10-8","Not discussed","Not discussed","P < 10−6",NA,NA,"Not discussed","32","Not discussed","Not discussed",NA,"Inverse variance weighted (fixed effects)","Overidentification tests",NA,NA,NA,NA,"Not clear what main analysis is - It's not actually clear in the methods what the authors did as their main analysis - they literally just say ""our primary MR analyses, we used each SNP and BMI polygenic scores to predict AD or dementia probability in logistic regression models to estimate odds ratios and 95% confidence intervals"" The over identification tests were used to compare the effect estimates from the 4 mechanism-specific polygenic scores - stating ""If associations between mechanism-specific scores and AD risk are statistically different, this would imply either a direct pathway linking genetic variants to AD that is not mediated by BMI, or that the different genetic subscores influence distinct types of adiposity, which in turn have distinct consequences on AD""","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","No","Not clear - they just say ""unit"" and then specify that BMI is measured in kg/m2 without much information in analyses section","Odds ratio","OR","0.95",NA,"95","0.91","1","5.8000000000000003E-2",NA,NA,"One caveat to our analyses is that BMI may be relevant for AD only above a certain threshold. Another concern is related to survivor bias. Both ADGC and the GERAD1 sample are AD case control studies among older individuals. BMI has strong and age-dependent links to mortality[40], thus our samples may have included a highly selected subgroup of “survivors” immune to the effects of obesity. A very similar bias should apply to conventional observational studies, however, so it is unlikely that this bias could explain differences between our results and previous work.","These SNPs were not associated with AD in ADGC or dementia in HRS. This does not conclusively prove the validity of our approach, but we note that even if there is modest pleiotropy, it is unlikely to explain our unexpected null associations.","Not discussed - they just state that they adjusted for principal components in their analyses to overcome population stratification","Statistical power is a common limitation in MR analyses, but the CIs in our analyses are informative and exclude any but very tiny harmful effects of BMI.","The authors also did some sensitivity analyses whereby they split the 32 SNP into four functional categories - adipogenesis, appetite, cardiopulmonary factors, and BMI-related processes not otherwise specified.",1476
104,"no","yes","Body Mass Index and Risk of Alzheimer’s Disease: A Mendelian Randomization Study of 399,536 Individuals",2017,"Journal of Clinical Endocrinology and Metabolism","10.1210/jc.2017-00195","Nordestgaard","Ruth Frikke-Schmidt","ruth.frikke-schmidt@regionh.dk.","Department of Clinical Biochemistry, KB 3011, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark.","Effect of body mas index on Alzheimers disease","Recently, data on 2,000,000 people established that low body mass index (BMI) is associated
with increased risk of dementia. Whether this observational association reflects a causal
effect remains to be clarified.","One-sample","alzheimer's disease","alzheimer's disease","brain","Information on diagnoses of Alzheimer’s disease was collected from the national Danish Patient Registry with data on all patient contacts from all clinical hospital departments in Denmark since 1977, including emergency wards and outpatient
clinics from 1995, and from the national Danish Causes of Death Registry with data on causes of all deaths in Denmark, as reported by hospitals and general practitioners since 1977. Alzheimer’s disease was World Health Organization International Classification of Diseases (ICD) ICD8 290 and ICD10 F00 and G30. The validity of Alzheimer’s disease ICD codes from the Danish registries is high (16), and was further ensured by the presence of thewell-known association with the apolipoprotein E «4 allele in the present cohort","Current study","20-100+","both","645","94933",NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","Age range in the Speliotes paper is 14-108","both","249796","249796",NA,"Healthy","European","age and sex",NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Chi-square",NA,NA,"5","32","Chose the top 5 striongest SNPs","Not discussed",NA,"Two-stage-least-squares",NA,NA,NA,NA,NA,NA,"F-statistic","Stata","ivreg2 and ivpois","Not discussed","Not discussed","Not discussed","1kg/m2 lower BMI","Odds ratio for risk of Alzheimer's risk","OR","0.98",NA,"95","0.77","1.1299999999999999","0.84",NA,NA,"The reason for this is that the associations of the genetic variants with BMI are relatively small, and therefore, large numbers of cases
and controls are required to reliably preclude any causal relation. A limitation
could be the observation that genetically low BMI is associated with low risk of hypertension. This is expected, as a causal relationship exists between high BMI and hypertension (36). However, because genetically low BMI is associated with low risk of hypertension, and because low risk of hypertension is associated with low risk of Alzheimer’s disease, these associations cannot explain the present observational relation between low BMI and high risk of Alzheimer’s disease.","Not discussed","They mention that their findings are based in a large homogenous population such that they can control for a number of important confounders and they included a positive control","Not discussed","This is the weighted allele score group and the resul using the simple unweighted score is similar",1480
104,"no","yes","Body Mass Index and Risk of Alzheimer’s Disease: A Mendelian Randomization Study of 399,536 Individuals",2017,"Journal of Clinical Endocrinology and Metabolism","10.1210/jc.2017-00195","Nordestgaard","Ruth Frikke-Schmidt","ruth.frikke-schmidt@regionh.dk.","Department of Clinical Biochemistry, KB 3011, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark.","Effect of body mas index on Alzheimers disease","Recently, data on 2,000,000 people established that low body mass index (BMI) is associated
with increased risk of dementia. Whether this observational association reflects a causal
effect remains to be clarified.","Two-sample summary-level","alzheimer's disease","alzheimer's disease","brain","Alzheimer's disease cases","IGAP Not reported  European both","Not discussed","both","17008","37154","17008","37154",NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","Age range in the Speliotes paper is 14-108","both","249796","249796",NA,"Healthy","European","age, age squared and sex.",NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed in the Speliotes paper",NA,NA,"32","32","This was a sensitivity analysis to the previous row (main analysis)","Not discussed",NA,"Inverse variance weighted",NA,NA,NA,NA,NA,"This was a sensitivity analysis to the row above, which was a one-sample MR","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Odds ratio for risk of Alzheimer's risk","OR","1.02",NA,"95","0.86","1.22","0.04",NA,NA,"The reason for this is that the associations of the genetic variants with BMI are relatively small, and therefore, large numbers of cases
and controls are required to reliably preclude any causal relation. A limitation
could be the observation that genetically low BMI is associated with low risk of hypertension. This is expected, as a causal relationship exists between high BMI and hypertension (36). However, because genetically low BMI is associated with low risk of hypertension, and because low risk of hypertension is associated with low risk of Alzheimer’s disease, these associations cannot explain the present observational relation between low BMI and high risk of Alzheimer’s disease.","Not discussed","They mention that their findings are based in a large homogenous population such that they can control for a number of important confounders and they included a positive control","Not discussed","This is the weighted allele score group and the resul using the simple unweighted score is similar",1481
109,"no","yes","Associations between Potentially Modifiable
Risk Factors and Alzheimer Disease: A
Mendelian Randomization Study",2015,"PLOS Mecicine","10.1371/journal.pmed.1001841","Østergaard","Robert Scott","Robert.Scott@mrc-epid.cam.ac.uk","MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom","Effect of body mass index on Alzheimers","Potentially modifiable risk factors including obesity, diabetes, hypertension, and smoking are associated with Alzheimer disease (AD) and represent promising targets for intervention. However, the causality of these associations is unclear. We sought to assess the causal nature of these associations using Mendelian randomization (MR)","Two-sample summary-level","alzheimer's disease","alzheimer's disease","brain","Defined in individual GWASs","Lambert  2013 Alzaheimers European  both","51-84","both","17008","37154","25580","48466","Just used stage 1 of GWAS ","Case/control","European ancestry","BMI","BMI","Speliotes 2010 BMI Europeans both",NA,"both","not reported","249796","not reported","healthy","European","Not discussed","Not discussed","R2 < 0.01","Excluded SNPs with a more significant association with AD than expectedby chance (p < 0.05/302 = 0.00017)","5x10-8","Not discussed","R2 (> 0.8; except for rs4420638, where the best available proxy was rs6857 (R2 = 0.46))","Not discussed",NA,"32",NA,"32",NA,"Not discussed",NA,"Inverse variance weighted","Excluded SNPs associated with outcome",NA,NA,NA,NA,"Consistent with main analysis","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","case/control","OR","0.99",NA,"95","0.8","1.19","0.77900000000000003","Not discussed","Not discussed","Potential limitations of this study include the small proportion of intermediate trait variance explained by genetic variants and other implicit limitations of MR analyses","Not disucssed - but removed SNPs assoiated with alzheimers in sensitivity analyses which was consisitent with main","Not discussed","Limited strength of the SNPs to explain variation inthe intermediate traits, restricting statistical power.",NA,1489
